297 related articles for article (PubMed ID: 19168442)
1. Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells.
Eisenreich A; Bogdanov VY; Zakrzewicz A; Pries A; Antoniak S; Poller W; Schultheiss HP; Rauch U
Circ Res; 2009 Mar; 104(5):589-99. PubMed ID: 19168442
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Cdc2-like kinase-family and DNA topoisomerase I on the alternative splicing of eNOS in TNF-alpha-stimulated human endothelial cells.
Eisenreich A; Boltzen U; Poller W; Schultheiss HP; Rauch U
Biol Chem; 2008 Oct; 389(10):1333-8. PubMed ID: 18713021
[TBL] [Abstract][Full Text] [Related]
3. Role of the phosphatidylinositol 3-kinase/protein kinase B pathway in regulating alternative splicing of tissue factor mRNA in human endothelial cells.
Eisenreich A; Malz R; Pepke W; Ayral Y; Poller W; Schultheiss HP; Rauch U
Circ J; 2009 Sep; 73(9):1746-52. PubMed ID: 19597299
[TBL] [Abstract][Full Text] [Related]
4. Cardiac glycosides regulate endothelial tissue factor expression in culture.
Stähli BE; Breitenstein A; Akhmedov A; Camici GG; Shojaati K; Bogdanov N; Steffel J; Ringli D; Lüscher TF; Tanner FC
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2769-76. PubMed ID: 18029910
[TBL] [Abstract][Full Text] [Related]
5. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
6. Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing.
Debdab M; Carreaux F; Renault S; Soundararajan M; Fedorov O; Filippakopoulos P; Lozach O; Babault L; Tahtouh T; Baratte B; Ogawa Y; Hagiwara M; Eisenreich A; Rauch U; Knapp S; Meijer L; Bazureau JP
J Med Chem; 2011 Jun; 54(12):4172-86. PubMed ID: 21615147
[TBL] [Abstract][Full Text] [Related]
7. Regulation and differential role of the tissue factor isoforms in cardiovascular biology.
Eisenreich A; Rauch U
Trends Cardiovasc Med; 2010 Aug; 20(6):199-203. PubMed ID: 22137642
[TBL] [Abstract][Full Text] [Related]
8. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines.
Szotowski B; Antoniak S; Poller W; Schultheiss HP; Rauch U
Circ Res; 2005 Jun; 96(12):1233-9. PubMed ID: 15920023
[TBL] [Abstract][Full Text] [Related]
9. Globular adiponectin but not full-length adiponectin induces increased procoagulability in human endothelial cells.
Bobbert P; Antoniak S; Schultheiss HP; Rauch U
J Mol Cell Cardiol; 2008 Feb; 44(2):388-94. PubMed ID: 18054040
[TBL] [Abstract][Full Text] [Related]
10. Increased human tumor necrosis factor-α levels induce procoagulant change in porcine endothelial cells in vitro.
Lee KG; Lee H; Ha JM; Lee YK; Kang HJ; Park CG; Kim SJ
Xenotransplantation; 2012; 19(3):186-95. PubMed ID: 22702470
[TBL] [Abstract][Full Text] [Related]
11. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
12. Caffeine induces endothelial tissue factor expression via phosphatidylinositol 3-kinase inhibition.
Gebhard C; Holy EW; Camici GG; Akhmedov A; Stämpfli SF; Stähli BE; von Rickenbach B; Breitenstein A; Greutert H; Yang Z; Lüscher TF; Tanner FC
Thromb Haemost; 2012 May; 107(5):884-94. PubMed ID: 22437887
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells.
Kim I; Oh JL; Ryu YS; So JN; Sessa WC; Walsh K; Koh GY
FASEB J; 2002 Jan; 16(1):126-8. PubMed ID: 11729102
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design.
Steffel J; Latini RA; Akhmedov A; Zimmermann D; Zimmerling P; Lüscher TF; Tanner FC
Circulation; 2005 Sep; 112(13):2002-11. PubMed ID: 16172265
[TBL] [Abstract][Full Text] [Related]
15. Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway.
Bea F; Puolakkainen MH; McMillen T; Hudson FN; Mackman N; Kuo CC; Campbell LA; Rosenfeld ME
Circ Res; 2003 Mar; 92(4):394-401. PubMed ID: 12600889
[TBL] [Abstract][Full Text] [Related]
16. SR protein kinases: the splice of life.
Stojdl DF; Bell JC
Biochem Cell Biol; 1999; 77(4):293-8. PubMed ID: 10546892
[TBL] [Abstract][Full Text] [Related]
17. Laminar shear, but not orbital shear, has a synergistic effect with thrombin stimulation on tissue factor expression in human umbilical vein endothelial cells.
Rochier A; Nixon A; Yamashita N; Abe R; Abe R; Madri JA; Sumpio BE
J Vasc Surg; 2011 Aug; 54(2):480-8. PubMed ID: 21367569
[TBL] [Abstract][Full Text] [Related]
18. Eicosapentaenoic acid and docosahexaenoic acid modulate mitogen-activated protein kinase activity in endothelium.
Xue H; Wan M; Song D; Li Y; Li J
Vascul Pharmacol; 2006 Jun; 44(6):434-9. PubMed ID: 16616699
[TBL] [Abstract][Full Text] [Related]
19. Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.
Fedorov O; Huber K; Eisenreich A; Filippakopoulos P; King O; Bullock AN; Szklarczyk D; Jensen LJ; Fabbro D; Trappe J; Rauch U; Bracher F; Knapp S
Chem Biol; 2011 Jan; 18(1):67-76. PubMed ID: 21276940
[TBL] [Abstract][Full Text] [Related]
20. Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibody.
Oku K; Amengual O; Zigon P; Horita T; Yasuda S; Atsumi T
Rheumatology (Oxford); 2013 Oct; 52(10):1775-84. PubMed ID: 23878313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
